|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$412,773
|
$412,773
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus
|
ZIA BC 011528
|
$5,039
|
$5,039
|
Agarwal, Piyush
|
CCR (NCI)
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
$51,467
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,287,528
|
$64,376
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Androgen Receptor in Bladder Cancer
|
ZIA BC 011527
|
$37,796
|
$37,796
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Applied Molecular Pathology Laboratory
|
ZIC BC 011257
|
$157,514
|
$7,876
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$4,862
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biostatistics Data Management Center for ACRIN
|
3U10CA079778-14S1
|
$2,271,308
|
$22,713
|
Gatsonis, Constantine
|
BROWN UNIVERSITY
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$253,796
|
$177,657
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$273,036
|
$273,036
|
Apolo, Andrea
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$46,939
|
$23,469
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$845,663
|
$84,566
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$536,933
|
$161,080
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
$687,138
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-32
|
$454,439
|
$31,811
|
Burstein, Harold
|
DANA-FARBER CANCER INST
|
|
Cancer and Leukemia Group B
|
5U10CA047577-26
|
$85,701
|
$5,999
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
3U10CA077597-14S2
|
$85,066
|
$5,955
|
CHESON, BRUCE
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-16
|
$194,694
|
$13,629
|
Hudis, Clifford
|
SLOAN-KETTERING INST CAN RES
|
|
Cancer and Leukemia Group B
|
5U10CA047559-23
|
$144,968
|
$10,148
|
Shea, Thomas
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B
|
5U10CA041287-28
|
$237,055
|
$16,594
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
5U10CA101140-11
|
$742,430
|
$51,970
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-16
|
$447,372
|
$31,316
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$10,873
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$80,549
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-35
|
$4,309,956
|
$301,697
|
SARGENT, DANIEL
|
MAYO CLINIC ROCHESTER
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-21
|
$175,386
|
$12,277
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$503,081
|
$50,308
|
Garfield, Susan
|
CCR (NCI)
|
|
Characterization of the interaction between inflammation and cancer progression
|
ZIA BC 010892
|
$287,493
|
$143,746
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Characterizing a novel tumor recognition mechanism
|
ZIA BC 010803
|
$92,612
|
$92,612
|
Yang, James
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$276,895
|
$138,447
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$939,734
|
$563,841
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$670,870
|
$33,544
|
Feldman, Steven
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$626,490
|
$469,867
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$85,879
|
$21,470
|
Bates, Susan
|
CCR (NCI)
|
|
Clustering of the drug activities of the NCI-60 cancerous cell lines
|
ZIC BC 011509
|
$43,100
|
$4,310
|
Reinhold, William
|
CCR (NCI)
|
|
Community Clinical Oncology Program
|
2U10CA035199-30
|
$363,406
|
$3,634
|
GRINBLATT, DAVID
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Computer-Aided Detection of Urinary Tract Cancer on MDCT Urography
|
5R01CA134688-04
|
$319,827
|
$159,914
|
Hadjiyski, Lubomir
|
UNIVERSITY OF MICHIGAN
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$874,946
|
$699,957
|
Young, Howard
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$1,073,256
|
$214,651
|
Meier, Jordan
|
CCR (NCI)
|
|
Development and use of nanoFACS for analysis and sorting of nanoparticles
|
ZIA BC 011502
|
$49,047
|
$2,452
|
Jones, Jennifer
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011349
|
$368,885
|
$18,444
|
Pack, Svetlana
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$79,567
|
$39,784
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$224,699
|
$67,410
|
Beutler, John
|
CCR (NCI)
|
|
EORTC HEADQUARTERS
|
4U10CA011488-43
|
$250,025
|
$2,500
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$41,217
|
N/A
|
National Cancer Institute
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
$104,878
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Florida Hospital Cancer Institute Community Clinical Oncology Program
|
5U10CA167730-02
|
$701,835
|
$7,018
|
Zehngebot, Lee
|
FLORIDA HOSPITAL
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$833,506
|
$416,753
|
Yang, James
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $17,558,503
|